Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02846649 · ClinicalTrials.gov registry record · NA

A Text Messaging Program to Help Prevent Early Opioid Relapse

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT02846649 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02846649, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The objective is to determine feasibility and acceptability of a text message (SMS)-based relapse prevention intervention as measured through: (1) study retention and SMS query completion rates and (2) participant ratings of PIER1 interest, perceived efficacy, and ease of use. Methods: A mixed methods study of adult (age \>=18) ED patients who seek treatment for opioids and have evidence of dependence based on Rapid Opioid Dependence Screen (RODS) score of \>3 and are being discharged to outpatient (community) resources. All participants receive standard of care in the ED, complete a baseline web survey, are asked to text with us for at least 7 days (up to a max of 28 days) and are asked to complete a follow-up phone call between day 8 and 14. Investigators expect preliminary findings to support a relapse prevention intervention delivered through SMS. Based on feedback from this mixed methods study, investigators plan to test a refined SMS program in a randomized trial.

Interventions

  • BEHAVIORAL PIER

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2016-08
Est. Completion 2016-12
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT02846649

The ClinicalTrials.gov registry entry for NCT02846649 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which PIER is the first listed.

NCT02846649 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02846649 about?

NCT02846649 is a clinical study titled "A Text Messaging Program to Help Prevent Early Opioid Relapse". The objective is to determine feasibility and acceptability of a text message (SMS)-based relapse prevention intervention as measured through: (1) study retention and SMS query completion rates and (2) participant ratings of PIER1 interest, perceived efficacy, and ease of use. Methods: A mixed metho...

What is the current status of trial NCT02846649?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-08. Estimated completion is 2016-12.

What interventions are being tested in trial NCT02846649?

The interventions under investigation include: PIER (BEHAVIORAL).

Who is sponsoring clinical trial NCT02846649?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.